What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Surgery, Internal medicine, Melanoma, Pancreaticoduodenectomy and Radiology.
His research brings together the fields of Pancreatic disease and Surgery.
His Internal medicine research includes elements of Gastroenterology, Oncology and Pathology.
His Melanoma research incorporates elements of Sentinel lymph node, Biopsy, Cancer and Lymph node.
His Pancreaticoduodenectomy research is multidisciplinary, incorporating perspectives in Pancreatectomy, Perioperative, Perineural invasion, Prospective cohort study and Adenocarcinoma.
The various areas that Jeffrey E. Lee examines in his Radiology study include Malignancy, Parathyroidectomy, Primary hyperparathyroidism and Lymphadenectomy.
His most cited work include:
- Genomic Classification of Cutaneous Melanoma (1491 citations)
- Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. (1091 citations)
- Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. (485 citations)
What are the main themes of his work throughout his whole career to date?
Jeffrey E. Lee spends much of his time researching Internal medicine, Surgery, Oncology, Melanoma and Cancer.
Many of his studies on Internal medicine apply to Gastroenterology as well.
As a member of one scientific family, he mostly works in the field of Surgery, focusing on Radiology and, on occasion, General surgery.
His Oncology study integrates concerns from other disciplines, such as Hazard ratio, Carcinoma, Pathology and Adjuvant therapy.
Jeffrey E. Lee has included themes like Sentinel lymph node, Single-nucleotide polymorphism and Lymph node in his Melanoma study.
His Cancer research incorporates themes from Stage and Genome-wide association study.
He most often published in these fields:
- Internal medicine (35.23%)
- Surgery (33.38%)
- Oncology (22.15%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (35.23%)
- Oncology (22.15%)
- Surgery (33.38%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Surgery, Cancer and Radiology are his primary areas of study.
In his research on the topic of Internal medicine, Retrospective cohort study, Preoperative care and Lymph node is strongly related with Gastroenterology.
His Oncology study combines topics in areas such as Carcinoma, Proportional hazards model, Melanoma, Single-nucleotide polymorphism and Adenocarcinoma.
His Melanoma study deals with the bigger picture of Cancer research.
His research integrates issues of Stage, Genome-wide association study and General surgery in his study of Cancer.
The concepts of his Pancreatectomy study are interwoven with issues in FOLFIRINOX, Pancreatic cancer and Pancreatic fistula.
Between 2016 and 2021, his most popular works were:
- B cells and tertiary lymphoid structures promote immunotherapy response (330 citations)
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (272 citations)
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study (209 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Internal medicine, Oncology, Pancreatectomy, Neoadjuvant therapy and Gastroenterology.
Hazard ratio, Cancer, Survival rate, Retrospective cohort study and Pancreatic cancer are among the areas of Internal medicine where the researcher is concentrating his efforts.
Jeffrey E. Lee interconnects Germline mutation, Surgery and Parathyroid carcinoma in the investigation of issues within Cancer.
Many of his studies on Surgery involve topics that are commonly interrelated, such as Parathyroidectomy.
His Oncology research includes themes of Carcinoma, Melanoma, Genotype, Stage and Adjuvant therapy.
His Neoadjuvant therapy study incorporates themes from Chemotherapy, Pancreatic ductal adenocarcinoma and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
